MedTrace Logo

Feasibility of the Implementation of Tools for Heart Failure Risk Prediction

NCT04684264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2024-03-20

No results posted yet for this study

Summary

The purpose of this study is to gather information to develop a heart failure screening and prevention program.

Conditions

Interventions

OTHER

Heart Failure Prevention Clinic

Heart Failure Prevention Clinic is a pharmacist-directed practice in collaboration with an attending cardiologist that uses evidence-based guidelines to optimize medications and lifestyle interventions for heart failure prevention.

Sponsors & Collaborators

Principal Investigators

  • Sadiya Khan, MD, MSc · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-03
Primary Completion
2023-08-30
Completion
2024-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04684264 on ClinicalTrials.gov